Examination of aortic diameter changes in patients after thoracic aortic aneurysm surgery with olmesartan or olmesartan + eplerenone
Phase 3
Recruiting
- Conditions
- thoracic aortic aneurysm with hypertension
- Registration Number
- JPRN-UMIN000014255
- Lead Sponsor
- Department of Cardiovascular Surgery,Tohoku University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
"Patients with thoracic aneurysm induced from congenital connective tissue disorder such as Marfan's syndrome" "Patients with thoracic aneurysm induced from autoimmune disorder such as aortitis syndrome" "Patients with chronic renal failure, which is more than 2.0mg/dL of serum creatinine concentration, or more than 2g of protein in urine daily" "Patients restricted to take olmesartan or eplerenone" "Patients during pregnancy or expecting to get pregnant" "Patients younger than 20" "Patinets refusing to anticipate this trial" "Patients which we judged unsuitable for this trial"
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method